{"id":8666,"date":"2021-12-17T01:52:51","date_gmt":"2021-12-17T06:52:51","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/glp-1-7-37-cas-106612-94-6-reduz-o-acucar-no-sangue-de-maneira-dependente-da-glicose-sem-quaisquer-reacoes-adversas\/"},"modified":"2021-12-17T01:52:51","modified_gmt":"2021-12-17T06:52:51","slug":"glp-1-7-37-cas-106612-94-6-reduz-o-acucar-no-sangue-de-maneira-dependente-da-glicose-sem-quaisquer-reacoes-adversas","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/pt-br\/product\/glp-1-7-37-cas-106612-94-6-reduz-o-acucar-no-sangue-de-maneira-dependente-da-glicose-sem-quaisquer-reacoes-adversas\/","title":{"rendered":"GLP-1 (7-37) CAS 106612-94-6 reduz o a\u00e7\u00facar no sangue de maneira dependente da glicose, sem quaisquer rea\u00e7\u00f5es adversas"},"content":{"rendered":"<h2><strong>GLP-1 (7-37) CAS 106612-94-6 N\u00edveis de glicose no sangue mais baixos sem quaisquer efeitos adversos<\/strong><\/h2>\n<p> Nome do produto: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU- PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH \/ GLP-1 (7-37)<br \/>\n Sin\u00f4nimos: Insulinotropina (humana); Pept\u00eddeo GLP-1 (pept\u00eddeo redutor de glicose humana -1); Glp-I (7-37); pept\u00eddeo semelhante ao glucagon I (7-37); pept\u00eddeo relacionado ao glucagon (oncorhynchus kisutch), \u00e1cido 3-L-glut\u00e2mico-6-L-fenilalanina-9-L-asp\u00e1rtico \u00e1cido-12-L-serina-15-L-\u00e1cido glut\u00e2mico-16-glicina-21-L-isoleucina-24-L-alanina-27-L-valina-28-L-lisina-31-glicina-; Tglp- 1; GLP-1, 7-37; Preproglucagon 78-108<br \/>\n CAS: 106612-94-6<br \/>\n MF: C151H228N40O47<br \/>\n MW: 3355,67<br \/>\n EINECS:<br \/>\n Categorias de produtos: pept\u00eddeos farmac\u00eauticos; pept\u00eddeo<br \/>\n Arquivo Mol: 106612-94-6.mol <\/p>\n<p> <strong>GLP-1 (7-37) CAS 106612-94-6 Propriedades qu\u00edmicas<\/strong><br \/>\n densidade 1,48 \u00b1 0,1 g \/ cm3 (previsto) &lt; &amp;&gt; temp. de armazenamento \u221220 \u00b0 C<br \/>\n Solubilidade em \u00e1gua Sol\u00favel em \u00e1gua a 2mg \/ ml<br \/>\n Refer\u00eancia CAS DataBase 106612-94-6 <\/p>\n<p> <strong>Fun\u00e7\u00e3o e Aplica\u00e7\u00e3o de GLP-1 (7-37) CAS 106612-94- 6<\/strong><br \/>\n Humanglucagon-likepPeptide -1 (GLP-1) \u00e9 um pequeno polipept\u00eddeo com 30 amino\u00e1cidos, que \u00e9 potente para reduzir o a\u00e7\u00facar no sangue de uma forma dependente da glicose sem quaisquer rea\u00e7\u00f5es adversas, al\u00e9m das m\u00faltiplas fun\u00e7\u00f5es do GLP-1 , torna-se um ponto importante de pesquisa na cura do diabetesII. Por\u00e9m, para realizar sua aplica\u00e7\u00e3o cl\u00ednica, \u00e9 urgente solucionar o problema de sua meia-vida curta in vivo. Conseq\u00fcentemente, as an\u00e1lises dos \u00faltimos avan\u00e7os na pesquisa e aplica\u00e7\u00e3o cl\u00ednica de GLP-1 na China e no exterior, com base em estudos anteriores, fornecer\u00e3o refer\u00eancia para pesquisadores e profissionais da \u00e1rea m\u00e9dica no desenvolvimento de medicamentos relevantes para GLP-1.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nome do produto: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE -ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH \/ GLP-1 (7-37)<br \/>\n CAS: 106612-94-6<br \/>\n MF: C151H228N40O47<br \/>\n MW: 3355,67 &lt; &amp;&gt; Arquivo Mol: 106612-94-6.mol<\/p>\n","protected":false},"featured_media":2297,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[357],"product_tag":[1072],"class_list":{"0":"post-8666","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptideo-diabetes","7":"product_tag-glp-1-7-37-cas-106612-94-6-reduce-blood-sugar-in-a-glucose-dependentmanner-without-any-adverse-reactions-pt-br","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product\/8666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/comments?post=8666"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/media\/2297"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/media?parent=8666"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product_brand?post=8666"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product_cat?post=8666"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product_tag?post=8666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}